New Cost-Saving Inhaler Added to Hampshire & Isle of Wight ICB Respiratory Formulary and the Wessex Adult and Adolescent Asthma Guidelines.

 

HIOW ICB has updated its respiratory inhaler choices, adding Proxor—a new branded generic inhaler—as a preferred option.

 

Proxor® is therapeutically equivalent to Fostair® pressurised metered dose inhaler (pMDI) for formulation and device characteristics and does not contain maleic acid as seen in other branded generics.

Proxor® is available to order in the UK priced at £9.90

 

For full prescribing details, visit: 

Proxor 100/6 microgram per actuation pressurised inhalation solution - Summary of Product Characteristics (SmPC) - (emc) | 100548

Proxor 200/6 micrograms per actuation pressurised inhalation solution - Summary of Product Characteristics (SmPC) - (emc) | 100549

 

Please see below the link to both the patient website for our respiratory products and the website for HCPs.

• www.stadarespiratory.co.uk for HCPs
• www.proxor.co.uk For Patients

 

 

QR Code - link to patient resources

 

Formulary and Implementation Support

We can provide full implementation support, including patient support materials, demonstration devices,  letter templates to help reduce administrative workload. I have attached some examples.  

If you require any placebo devices ,  hard copies of the MART Action plans or patient information leaflets, or have any questions, please contact your local  representative Sonya Brown at Sonyabrown@thorntonross.com